TL
Talis Biomedical Corporation
TLIS · OTC
$2.84 +0.00% (+$0.00)
Market Cap $5.18M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
50 /100
Fair P/B 0.07x
P/S 12.57x
EV/FFO N/A
Growth
0 /100
Declining Rev. growth 66.48%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 16,217.20%
Gross margin 90.05%
FCF margin 13,040.30%
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 75.26%
ROA 65.50%
Debt
96 /100
Low Net debt/EBITDA 0.86x
Debt/Equity 0.28x
Current ratio 8.86x
Stability
61 /100
Moderate Profitable years 0
Beta 1.32x
EPS volatility 7.03%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o TLIS
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Rebecca Markovich
Employees
99
Headquarters
Menlo Park